Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 10,143 | 497 | 2,775 | 909 | 449 |
| Gross Profit | 10,143 | 497 | 2,800 | 909 | 449 |
| Operating Expenses | 19,316 | 13,717 | 12,264 | 9,244 | 6,674 |
| Operating Income | -9,173 | -13,220 | -9,489 | -8,335 | -6,225 |
| Other Income | 826 | 563 | 206 | 163 | 72 |
| Pre-tax Income | -8,347 | -12,657 | -9,283 | -8,172 | -6,153 |
| Net Income Continuous | -8,347 | -12,657 | -9,277 | -8,172 | -6,153 |
| Net Income | $-8,347 | $-12,657 | $-9,277 | $-8,172 | $-6,153 |
| EPS Basic Total Ops | -25.90 | -51.80 | -129.50 | -115.11 | -87.05 |
| EPS Basic Continuous Ops | -26.26 | -51.79 | -129.57 | -114.92 | -86.93 |
| EPS Diluted Total Ops | -25.90 | -51.80 | -129.50 | -115.11 | -87.05 |
| EPS Diluted Continuous Ops | -26.26 | -51.79 | -129.57 | -114.92 | -86.93 |
| EBITDA(a) | $-9,369 | $-13,338 | $-9,497 | $-8,348 | $-6,183 |